☆ 4.8 Letter

Cardiovascular Assessment up to One Year After COVID-19 Vaccine-Associated Myocarditis

CIRCULATION (2023)

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

Multiparametric Cardiovascular Magnetic Resonance Approach in Diagnosing, Monitoring, and Prognostication of Myocarditis

Christian Eichhorn et al.

Summary: Myocarditis, characterized by inflamed myocardium with heterogeneous presentation, poses a diagnostic challenge. Contemporary noninvasive evaluation techniques, such as cardiac magnetic resonance (CMR), including various methods like CMR feature-tracking and artificial intelligence, can improve the diagnosis and prognosis of myocarditis, providing valuable information for clinical decision making, monitoring, and risk stratification.

JACC-CARDIOVASCULAR IMAGING (2022)

Add to Collection
Article Pediatrics

Persistent Cardiac Magnetic Resonance Imaging Findings in a Cohort of Adolescents with Post-Coronavirus Disease 2019 mRNA Vaccine Myopericarditis

Jenna Schauer et al.

Summary: This study describes the evolution of cardiac magnetic resonance imaging findings in 16 patients aged 12-17 years with myopericarditis after receiving the second dose of the Pfizer mRNA coronavirus disease 2019 vaccine. While all patients showed rapid clinical improvement, many had persistent cardiac magnetic resonance imaging findings at 3- to 8-month follow-up.

JOURNAL OF PEDIATRICS (2022)

Add to Collection
Letter Cardiac & Cardiovascular Systems

Follow-Up Cardiovascular Magnetic Resonance Findings in Patients With COVID-19 Vaccination-Associated Acute Myocarditis

Yash R. Patel et al.

JACC-CARDIOVASCULAR IMAGING (2022)

Add to Collection
Article Pediatrics

Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study

Ian Kracalik et al.

Summary: This study investigated the long-term clinical outcomes and quality of life in individuals with myocarditis after mRNA COVID-19 vaccination. The findings showed that most patients were considered recovered by healthcare providers at least 90 days after the onset of myocarditis, and their quality of life was comparable to pre-pandemic and early pandemic populations of a similar age.

LANCET CHILD & ADOLESCENT HEALTH (2022)

Add to Collection
Article Medicine, General & Internal

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

D. Mevorach et al.

Summary: The incidence of myocarditis increased after receiving the BNT162b2 vaccine in Israel, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.